Analystreport

Harvard Bioscience (NASDAQ:HBIO) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.

Harvard Bioscience, Inc.  (HBIO) 
Last harvard bioscience, inc. earnings: 2/26 07:15 am Check Earnings Report
US:NASDAQ Investor Relations: investor.harvardbioscience.com